Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (63)
  • 2025 (95)
  • 2024 (63)
  • 2023 (26)
  • 2022 (28)
  • 2021 (48)
  • 2020 (40)
  • 2019 (60)
  • 2018 (84)
  • 2017 (96)
  • 2016 (76)
  • 2015 (74)
  • 2014 (64)
  • 2013 (62)
  • 2012 (23)
  • 2011 (39)

Subject

  • Arrests/Convictions - Major (148)
  • Drug Trafficking (57)
  • Take Back Day (40)
  • Prescription Drugs (33)
  • Outreach/Drug Prevention (32)
  • Public and Media Affairs - also see Congressional Affairs (21)
  • Diversion Division (19)
  • Fake Pills (19)
  • Synthetic drugs (18)
  • Fentanyl Awareness (17)
  • Guns/Weapons (15)
  • Major Law Enforcement Operation (15)
  • Pharmaceuticals/Pharmacists/Physicians (14)
  • Press Conferences (13)
  • Congressional Affairs (12)
  • Fentanyl Free America (11)
  • One Pill Can Kill (11)
  • Money Laundering (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (10)
  • Red Ribbon (9)
  • Overdose (8)
  • Gangs (6)
  • OCDETF/Task Force (6)
  • Seizures (Drugs/Property) (6)
  • Asset Forfeiture (5)
  • Extraditions (5)
  • International/Foreign Operations (5)
  • Narcoterrorism (5)
  • Intergovernmental Affairs (4)
  • Other (4)
  • Task Forces/Task Force Officers (4)
  • Campaigns (3)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Scam Calls (3)
  • Cartel (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Guilty Plea (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)

Drug Name

  • Fentanyl (71)
  • Methamphetamine (54)
  • Cocaine (41)
  • Heroin (19)
  • Oxycodone (12)
  • Marijuana (Cannabis) (10)
  • Synthetic Opioids (9)
  • Opioids (5)
  • Ecstasy/MDMA (3)
  • Ketamine (2)
  • Marijuana Concentrates (2)
  • GHB (1)
  • Methadone (1)
  • Psilocybin (1)

Field Division

  • Atlanta (802)
  • Caribe (96)
  • Caribe (1)
  • Chicago (651)
  • Dallas (330)
  • Detroit (368)
  • El Paso (360)
  • Houston (926)
  • Los Angeles (316)
  • Louisville (96)
  • Miami (894)
  • New England (2470)
  • New Jersey (499)
  • New Orleans (514)
  • New York (1550)
  • Omaha (157)
  • Philadelphia (140)
  • Phoenix (278)
  • Rocky Mountain (169)
  • San Diego (251)
  • San Francisco (864)
  • Seattle (844)
  • Sede (433)
  • St. Louis (821)
  • Washington, DC (621)
Clear All Results
941 Results - Showing 341 to 350
PRESS RELEASE

Former member of Venezuelan National Assembly charged with narco-terrorism, drug trafficking and weapons offenses

NEW YORK – DEA Acting Administrator Timothy J. Shea and United States Attorney for the Southern District of New York Geoffrey S. Berman announced today that Adel El Zabayar was charged in Manhattan federal court with participating in a narco-terrorism conspiracy, a cocaine importation conspiracy, and related weapons offenses involving...
PRESS RELEASE

DEA podcast about drug misuse among college students wins award

WASHINGTON – The U.S. Drug Enforcement Administration’s podcast series, Prevention Profiles: Take Five , has received a Second Place Blue Pencil & Gold Screen Award from the National Association of Government Communicators. Prevention Profiles: Take Five highlights issues related to preventing drug misuse among college students. Each podcast episode is...
PRESS RELEASE

Attorney General Barr announces Timothy J. Shea as new Acting Administrator of Drug Enforcement Administration

WASHINGTON – Today, Attorney General William P. Barr announced the appointment of Timothy J. Shea as Acting Administrator of the Drug Enforcement Administration. “I am pleased to appoint Tim Shea as DEA Acting Administrator,” said Attorney General Barr. “A highly regarded public servant, Tim’s long career in both federal and...
PRESS RELEASE

Alleged narcotrafficker and high ranking cartel member extradited from Uruguay to the United States

WASHINGTON – A Mexican national will have his initial appearance in federal court in the District of Columbia later today on charges related to his alleged involvement in a criminal conspiracy to distribute cocaine and methamphetamine. Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division and Acting...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
PRESS RELEASE

Former chief of Honduran National Police charged with drug trafficking and weapons offenses

NEW YORK – DEA Special Operations Division Special Agent in Charge Wendy Woolcock and United States Attorney for the Southern District of New York Geoffrey S. Berman announced today that Juan Carlos Bonilla Valladares, aka “El Tigre,” was charged in Manhattan federal court with conspiring to import cocaine into the...
PRESS RELEASE

DEA launches Secure Your Meds campaign, calls on Americans to keep medications safe

WASHINGTON – With families encouraged to stay at home due to the nationwide health crisis, the Drug Enforcement Administration is asking Americans to keep prescription medications safe and secure until they can properly dispose of them. The Secure Your Meds awareness campaign addresses a vital public safety and health issue...
PRESS RELEASE

DEA releases 2020 Drugs of Abuse Resource Guide

WASHINGTON – The U.S. Drug Enforcement Administration has released the 2020 edition of Drugs of Abuse, A DEA Resource Guide , which is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. Released on a periodic basis, Drugs of Abuse provides...
PRESS RELEASE

DEA takes additional steps to allow increased production of controlled substances used in COVID-19 care

WASHINGTON – The Drug Enforcement Administration announced today that it is increasing Aggregate Production Quotas available to pharmaceutical manufacturers for the production of controlled substance medications that are in high demand due to the coronavirus (COVID-19) pandemic. DEA will also approve increases in imports of medications necessary for patients on...
PRESS RELEASE

National Prescription Drug Take Back Day Postponed

WASHINGTON – The upcoming National Prescription Drug Take Back Day scheduled for Saturday, April 25, 2020 is postponed due to the ongoing coronavirus (COVID-19) pandemic. DEA will reschedule Take Back Day for a date shortly after the health crisis recedes and national emergency guidelines are lifted. The health and safety...

Paginación

  • Primera página «
  • Anterior
  • Página 31
  • Página 32
  • Página 33
  • Página 34
  • Current page 35
  • Página 36
  • Página 37
  • Página 38
  • Página 39
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster